The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents: A literature review
- PMID: 29626629
- DOI: 10.1016/j.anai.2018.03.028
The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents: A literature review
Abstract
Objective: To evaluate the literature regarding the burden of allergic rhinitis (AR) and allergic rhinoconjunctivitis (ARC) in adolescents (aged 10-19 years).
Data sources: Searches were performed in MEDLINE, Embase, Health Technology Assessment Database, and National Health Service Economic Evaluation Database for studies that evaluated concepts of symptoms, quality of life (QOL), daily activities, sleep, examination performance, school absenteeism and presenteeism, and treatment burden in adolescents with AR or ARC.
Study selections: English-language journal articles indexed in the last 15 years describing noninterventional, population-based studies. Records were assessed by 2 independent reviewers.
Results: A total of 27 articles were identified; outcomes evaluated were symptoms (n = 6 studies), QOL (n = 9), daily activities (n = 5), emotional aspects (n = 3), sleep (n = 6), education (n = 7), and treatment burden (n = 2). AR symptoms rated most bothersome were rhinorrhea, nasal congestion, and itchy eyes. QOL was worse in adolescents with AR vs controls regardless of QOL instrument used. Nasal symptoms and nasal obstruction were more likely to be associated with poor QOL in adolescents than in adults or younger children, respectively. Daily functioning and sleep were also negatively affected by AR. In addition, a detrimental effect on absenteeism, school productivity, and academic performance was reported.
Conclusion: Although AR and ARC are sometimes perceived as trivial conditions, this review indicates that their effect on adolescent life is negative and far-reaching. It is critical that clinicians gain a greater understanding of the unique burden of AR and ARC in adolescents to ensure they receive prompt and appropriate care and treatment to improve clinical and academic outcomes.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Patient and healthcare-provider perspectives on the burden of allergic rhinitis.Allergy Asthma Proc. 2007 May-Jun;28 Suppl 1:S4-10. doi: 10.2500/aap.2007.28.2991. Allergy Asthma Proc. 2007. PMID: 18307838
-
Allergic rhinitis-induced nasal congestion: its impact on sleep quality.Prim Care Respir J. 2008 Mar;17(1):7-18. doi: 10.3132/pcrj.2008.00001. Prim Care Respir J. 2008. PMID: 18253678 Free PMC article. Review.
-
Allergic rhinitis: the impact of discordant perspectives of patient and physician on treatment decisions.Clin Ther. 2007 Jul;29(7):1428-40. doi: 10.1016/j.clinthera.2007.07.013. Clin Ther. 2007. PMID: 17825694
-
Sleep and allergic rhinitis.J Investig Allergol Clin Immunol. 2008;18(6):415-9. J Investig Allergol Clin Immunol. 2008. PMID: 19123431 Review.
-
Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients--an observational, cross sectional study in four countries in Europe.J Med Econ. 2011;14(3):305-14. doi: 10.3111/13696998.2011.576039. Epub 2011 Apr 14. J Med Econ. 2011. PMID: 21488807
Cited by
-
Development and validation of a tool for the assessment of benefit from treatment of allergic rhinitis in children and adolescents (PBI-AR-K).Allergy Asthma Clin Immunol. 2022 Oct 25;18(1):95. doi: 10.1186/s13223-022-00733-8. Allergy Asthma Clin Immunol. 2022. PMID: 36284348 Free PMC article.
-
Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis.Clin Transl Allergy. 2022 Oct 5;12(10):e12191. doi: 10.1002/clt2.12191. eCollection 2022 Oct. Clin Transl Allergy. 2022. PMID: 36225263 Free PMC article.
-
Cetirizine for the treatment of allergic diseases in children: A systematic review and meta-analysis.Front Pediatr. 2022 Aug 25;10:940213. doi: 10.3389/fped.2022.940213. eCollection 2022. Front Pediatr. 2022. PMID: 36090559 Free PMC article.
-
Cell division cycle 42 reflects disease risk, symptoms, Th1/Th2 disproportion, and its short-term variation indicates symptom amelioration after treatment in allergic rhinitis patients.J Clin Lab Anal. 2022 Oct;36(10):e24684. doi: 10.1002/jcla.24684. Epub 2022 Aug 31. J Clin Lab Anal. 2022. PMID: 36045593 Free PMC article.
-
The MaDo real-life study of dose adjustment of allergen immunotherapy liquid formulations in an indication of respiratory allergic disease: Reasons, practices, and outcomes.Front Allergy. 2022 Aug 9;3:971155. doi: 10.3389/falgy.2022.971155. eCollection 2022. Front Allergy. 2022. PMID: 36017469 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
